Management of Recurrent Ewing's Sarcoma With Vigil–Temozolomide–Irinotecan and Assessment of ctDNA
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Pilot Study of recurrent Ewing's Sarcoma management with Vigil/Temozolomide/Irinotecan and assessment of circulating tumor (ct) DNA
Clin. Cancer Res 2023 Mar 16;[EPub Ahead of Print], P Anderson, M Ghisoli, BD Crompton, KS Klega, LH Wexler, EK Slotkin, L Stanbery, L Manning, G Wallraven, M Manley, S Horvath, E Bognar, J NemunaitisFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.